Biomarker

Evidence of association between aerosol properties and in-vitro cellular oxidative response to PM1, oxidative potential of PM2.5, a biomarker of RNA oxidation, and its dependency on combustion sources

The causal link between ambient PM2.5 and adverse health effects is still not clear enough, nor it is clear what factors (physical and/or chemical) contribute to PM2.5 toxicity and by what mechanism(s).

Circulating miR-127-3p as a Potential Biomarker for Differential Diagnosis in Frontotemporal Dementia

Given the heterogeneous nature of frontotemporal dementia (FTD), sensitive biomarkers are greatly needed for the accurate diagnosis of this neurodegenerative disorder. Circulating miRNAs have been reported as promising biomarkers for neurodegenerative disorders and processes affecting the central nervous system, especially in aging.

Leukocyte telomere shortening in Huntington's disease

Huntington's disease (HD) is an autosomal dominant neurodegenerative disease caused by an expanded CAG repeat. Though symptom onset commonly occurs at midlife and inversely correlates with the CAG repeat expansion, age at clinical onset and progression rate are variable. In the present study we investigated the relationship between leukocyte telomere length (LTL) and HD development. LTL was measured by real-time PCR in manifest HD patients (HD, n = 62), pre-manifest HD patients (pre-HD, n = 38), and age-matched controls (n = 76).

L’integrazione tra le scienze sociali e le scienze biologiche nelle biosocial surveys

Biosocial surveys are becoming increasingly popular at an international level as a new type of survey. The expression «biosocial survey» refers to research designed to gather two different types of information from individuals: bi-omarkers and answers to questions of more traditional survey topics, such as at-titudes, opinions, lifestyle, etc.

The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

Background: The heterogeneity of metastatic breast cancer (MBC) necessitates novel biomarkers allowing stratification of patients for treatment selection and drug development. We propose to use the prognostic utility of circulating tumor cells (CTCs) for stratification of patients with stage IV disease.Methods: In a retrospective, pooled analysis of individual patient data from 18 cohorts, including 2436 MBC patients, a CTC threshold of 5 cells per 7.5 ml was used for stratification based on molecular subtypes, disease location, and prior treatments.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma